Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Country, Double-Blind, Randomized, 2-Arm, Parallel-Group Study, Evaluating Efficacy and Safety of Rimonabant 20 mg OD, With/Without Association of Nicotine Patch, as Aid to Smoking Cessation During 9-Week Period

NCT00458718 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00458718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00458718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Country, Double-Blind, Randomized, 2-Arm, Parallel-Group Study, Evaluating Efficacy and Safety of Rimonabant 20 mg OD, With/Without Association of Nicotine Patch, as Aid to Smoking Cessation During 9-Week Period
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
July 31, 2005
Enrollment
755 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation